膀胱切除术前输尿管支架置入是上尿路复发的独立危险因素
该回顾性研究分析了2000年1月至2016年6月在本院接受根治性膀胱切除术的1005例连续膀胱癌患者,评估术前逆行支架置入是否增加上尿路复发风险。结果显示,Double-J支架组上尿路复发率为13%(7/53),经皮肾造瘘组为0%,未引流组为3%(24/891);多因素回归分析显示Double-J支架置入(HR 4.54,95%CI 1.43-14.38,p=0.01)和术前膀胱内灌注(HR 2.94,95%CI 1.40-6.16,p=0.004)与上尿路复发风险升高相关。作者认为,若术前需上尿路引流,可考虑经皮引流。
要点
- 根治性膀胱切除术前Double-J支架置入与上尿路复发风险升高相关(HR 4.54,95%CI 1.43-14.38,p=0.01)。
- 术前膀胱内灌注亦与上尿路复发风险升高相关(HR 2.94,95%CI 1.40-6.16,p=0.004)。
- Double-J支架组上尿路复发率为13%(7/53),经皮肾造瘘组为0%,未引流组为3%(24/891)。
核心结论
- 根治性膀胱切除术前接受Double-J支架置入的患者上尿路复发风险更高。
- 若术前需上尿路引流,作者建议可考虑经皮引流。
研究设计与样本
- 回顾性分析2000年1月至2016年6月在本院接受根治性膀胱切除术的1005例连续膀胱癌患者记录,术中输尿管切缘阴性为入选必要条件。
主要发现
- 1005例患者中114例(11%)术前接受上尿路引流,其中53例(46%)为Double-J支架置入,61例(54%)为经皮肾造瘘。
- 31例(3%)在膀胱切除术后中位17个月出现上尿路复发,其中Double-J组7/53(13%),肾造瘘组0%,未引流组24/891(3%)。
- 多因素回归分析显示Double-J支架置入(HR 4.54,95%CI 1.43-14.38,p=0.01)和术前膀胱内灌注(HR 2.94,95%CI 1.40-6.16,p=0.004)与上尿路复发风险升高相关。
临床怎么用
- 作者认为,若术前需上尿路引流,可考虑经皮引流。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients with bladder cancer who present with hydronephrosis may require drainage of the affected kidney before receiving further cancer treatment. Drainage can be done by retrograde stenting or percutaneously. However, retrograde stenting carries the risk of tumor cell spillage to the upper urinary tract. The aim of this study was to evaluate whether patients with bladder cancer are at higher risk for upper urinary tract recurrence if retrograde stenting has been performed prior to radical cystectomy. MATERIALS AND METHODS: We retrospectively analyzed the records of 1,005 consecutive patients with bladder cancer who underwent radical cystectomy at our department between January 2000 and June 2016. Negative intraoperative ureteral margins were mandatory for study inclusion. Patients received regular followup according to our institutional protocol, including imaging of the upper urinary tract and urine cytology. RESULTS: Preoperative drainage of the upper urinary tract was performed in 114 of the 1,005 patients (11%), including in 53 (46%) by Double-J® stenting and in 61 (54%) by percutaneous nephrostomy. Recurrence developed in the upper urinary tract in 31 patients (3%) at a median of 17 months after cystectomy, including 7 of 53 (13%) in the Double-J group, 0% in the nephrostomy group and 24 of 891 (3%) in the no drainage group. Multivariate regression analysis revealed a higher risk of upper urinary tract recurrence if patients underwent Double-J stenting (HR 4.54, 95% CI 1.43-14.38, p = 0.01) and preoperative intravesical instillations (HR 2.94, 95% CI 1.40-6.16, p = 0.004). CONCLUSIONS: Patients who undergo Double-J stenting prior to radical cystectomy are at higher risk for upper urinary tract recurrence. If preoperative upper urinary tract drainage is required, percutaneous drainage might be recommended.
引用
- Kiss B, Furrer MA, Wuethrich PY, et al. Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence. J Urol. 2017. PMID: 28603003. doi:10.1016/j.juro.2017.06.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。